|
Markt geschlossen -
Hong Kong S.E.
09:08:15 17.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 10.50 HKD | -0.47% |
|
-4.81% | -12.28% |
| 16.11. | Simcere Pharma erhält in China Genehmigung für Studie zu Medikament gegen atopische Dermatitis | MT |
| 16.11. | Simceres sublinguale Sanbexin-Tabletten in Chinas Erstattungsliste aufgenommen | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.47% | -4.81% | -4.02% | -15.12% | -12.28% | -23.80% | +44.23% | +24.41% | - | 3.45 Mrd. | ||
| -0.82% | +1.40% | +13.89% | +21.31% | +33.22% | +39.64% | +143.17% | +455.51% | +1’760.76% | 1’275 Mrd. | ||
| -1.12% | +0.16% | +10.56% | +8.53% | +36.53% | +44.21% | +88.24% | +73.70% | +142.82% | 680 Mrd. | ||
| -0.16% | +0.43% | +3.20% | +18.08% | +28.91% | +26.76% | +113.01% | +153.01% | +378.63% | 521 Mrd. | ||
| -0.49% | +1.37% | +7.16% | +14.38% | +24.10% | +41.82% | +71.42% | +9.84% | +73.91% | 389 Mrd. | ||
| -2.23% | -2.89% | -1.02% | +6.35% | +37.24% | +55.47% | +41.64% | +71.75% | +130.66% | 356 Mrd. | ||
| -0.62% | +0.33% | +8.63% | +9.34% | +23.10% | +27.55% | +60.43% | +77.01% | +85.58% | 305 Mrd. | ||
| -0.87% | +0.09% | +12.06% | +20.21% | +0.77% | +2.24% | +35.44% | +61.77% | +220.18% | 287 Mrd. | ||
| -0.72% | -0.63% | +6.90% | +11.35% | +41.25% | +37.29% | +71.87% | +125.09% | +214.01% | 250 Mrd. | ||
| -0.30% | -1.03% | +7.29% | +21.12% | +36.53% | +34.04% | +124.88% | +150.53% | +120.50% | 208 Mrd. | ||
| -1.41% | +3.57% | +9.63% | -3.83% | -13.54% | -10.07% | -59.50% | -25.37% | +144.73% | 185 Mrd. | ||
| -0.10% | -1.27% | -2.43% | +7.73% | +15.90% | +15.16% | -3.06% | -41.81% | -9.70% | 164 Mrd. | ||
| -0.15% | -2.37% | +7.61% | +6.34% | +18.62% | +23.02% | +56.79% | +185.56% | +494.44% | 136 Mrd. | ||
| -0.79% | +1.27% | +5.32% | -1.41% | +16.67% | +34.90% | +23.78% | +6.48% | +11.98% | 129 Mrd. | ||
| +0.20% | +4.31% | +9.97% | +27.16% | +34.71% | +31.23% | +145.14% | +400.90% | +681.06% | 128 Mrd. | ||
| -0.24% | +2.51% | +24.08% | +14.94% | +6.52% | -1.98% | +2.58% | -2.75% | +14.09% | 116 Mrd. | ||
| -0.74% | -0.21% | +3.13% | +3.32% | +4.85% | +6.31% | +35.62% | -1.83% | +0.45% | 102 Mrd. | ||
| -0.32% | +3.53% | +20.44% | +18.53% | +23.39% | +37.33% | +19.57% | +48.18% | +126.72% | 95.57 Mrd. | ||
| -3.63% | -19.97% | -1.26% | +239.97% | +629.98% | +769.08% | +181.21% | -8.11% | - | 87.1 Mrd. | ||
| -0.54% | +2.49% | +15.88% | +6.93% | -10.95% | -13.68% | +49.70% | +76.82% | +562.26% | 76.08 Mrd. | ||
| Durchschnitt | -0.77% | -0.23% | +7.85% | +21.76% | +48.78% | +58.83% | +62.31% | +92.03% | +286.28% | 275 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.80% | +0.63% | +8.89% | +17.48% | +35.81% | +43.34% | +83.70% | +167.23% | +558.92% |
- Börse
- Aktien
- A2QD9S Aktie
- Sektor Simcere Pharmaceutical Group Limited
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
















